To,
Management Team
MJ Biopharma
Subject: Proposal for Manufacturing & Strategic Support for Dedicated Insulin Division
Dear Sir/Madam,
We would like to introduce TCSOL Biopharma as a professionally managed pharmaceutical company engaged in manufacturing, marketing, and institutional supply of pharmaceutical and healthcare products across India.
TCSOL Biopharma has established a strong presence in Government and Defence healthcare sectors, including Army, Navy, and Air Force Hospitals nationwide. The company operates under valid pharmaceutical licences and certifications, including:
UDYAM Registration
UDYAM-TN-02-0153340
Drug Licences
HR/WLF20B2023HR0345
HR/WLF21B2024HR0343
Manufacturing Loan Licences
L/22/2864/MNB
L/22/2865/MB
Certifications
GMP & GLP Certified manufacturing support
As part of our future expansion strategy, we are planning to launch a dedicated Diabetic & Insulin Care Division, which will exclusively focus on insulin products and diabetic healthcare solutions.
Considering the rapidly increasing diabetic population in India and the growing demand for affordable and reliable insulin therapies, we believe this specialized division has strong long-term business potential.
- Manufacturing insulin products
- Product development support
- Regulatory and technical guidance
- Supply and production collaboration
- Manufacturing under our own brand name
Our objective is to market and promote the complete insulin range under the TCSOL Biopharma brand through our existing institutional and pharmaceutical network across India.
We believe that with the manufacturing expertise of MJ Biopharma and the institutional market presence of TCSOL Biopharma, this collaboration can create a strong and successful business partnership in the diabetic healthcare segment.
✓
Develop the insulin segment aggressively
✓
Build nationwide distribution channels
✓
Support large-volume institutional requirements
✓
Expand diabetic healthcare accessibility
✓
Establish long-term strategic business growth
We look forward to your positive response and the opportunity to discuss this proposal further.